> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç
Á¦¸ñ | 2022³â 9¿ù 7ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª | ||
---|---|---|---|
ÀÛ¼ºÀÚ | °ü¸®ÀÚ | ÀÛ¼ºÀÏ | 2022-09-07 |
÷ºÎÆÄÀÏ | 1.png | 2.png | ||
¼¿ï´ëÇб³ »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿°íÀÚ ÇÏ¿À´Ï ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù. ¼¼¹Ì³ª´Â ¿ÀÇÁ¶óÀÎÀ¸·Î ¿¹Á¤µÇ¾î ÀÖÀ¸³ª, ZoomÀ» ÅëÇØ Âü¿©ÇÏ°íÀÚ ÇϽô ºÐ²²¼´Â ¾Æ·¡ÀÇ ¸µÅ©·Î Âü¿© ºÎŹµå¸®°Ú½À´Ï´Ù. *ÁÜÀ¸·Î Âü¼®Çϱâ À§Çؼ´Â "Âü¼®ÀڷΠȸÀÇ Âü°¡" --> À̸§, ¼º, À̸ÞÀÏ ÁÖ¼Ò, À̸ÞÀÏ ÁÖ¼Ò È®ÀÎÀ» ÀÔ·ÂÇÏ½Ã°í µî·ÏÇϽøé ȸÀÇ Âü¼®ÀÌ °¡´ÉÇÕ´Ï´Ù. ÀϽÃ: 2022³â 9¿ù 8ÀÏ ¸ñ¿äÀÏ ¿ÀÀü 11½Ã ¿¬»ç: ÀÌÀÎÇÑ ¹Ú»ç´Ô (University of Michigan) Title:¡¡Identifying functional mutations in noncoding regions in cancer We identified a novel mode of translation
regulation of untranslated regions and, incorporating multiple datatypes, used
it to identify sequence variants which affect molecular functions in patient
populations. Utilizing this regulation model, we identified mutations in these
untranslated regions are abundant in WNT1, AXIN2, EGFR, KRAS, and ERBB2 of
colon adenocarcinoma, lung adenocarcinoma, and breast invasive carcinoma (BRCA)
patients. Currently, few BRCA patients qualify for EGFR-specific drugs.
Combining SNP database and TCGA multi-platform datasets, we uncovered that EGFR
UTR-mutated BRCA patients lost overall miRNA and EGFR protein correlations,
indicative of unregulated EGFR protein expression. This increases the search
space for BRCA patients who might qualify for EGFR-specific drugs. |
|||